OTC Markets OTCPK - Delayed Quote ? USD Alterity Therapeutics Limited (PRNAF) Follow Compare 0.0036 0.0000 (0.00%) At close: October 31 at 4:00 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for PRNAF 1D 5D 0.00% 1M 0.00% 3M 0.00% YTD -18.18% 1Y -18.18% 2Y -56.63% 5Y -83.33% All -98.67% Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: PRNAF View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Appendix 4C – Q1 FY25 Quarterly Cash Flow Report GlobeNewswire ? yesterday Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024 GlobeNewswire ? 18 days ago Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting GlobeNewswire ? 21 days ago Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders? GlobeNewswire ? 30 days ago Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer GlobeNewswire ? last month Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders? GlobeNewswire ? last month Appendix 4C – Q4 FY24 Quarterly Cash Flow Report GlobeNewswire ? 3 months ago Alterity Therapeutics to Present at MST Financial Webinar GlobeNewswire ? 3 months ago Alterity (ATHE) Up on Interim Data From Advance MSA Study Zacks ? 3 months ago Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy GlobeNewswire ? 3 months ago Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar GlobeNewswire ? 4 months ago View More
